HLB Pharmaceutical Co. Ltd Working Capital to Net Assets Ratio
HLB Pharmaceutical Co. Ltd working capital to net assets ratio. HLB Pharmaceutical Co. Ltd (047920) has a Working Capital to Net Assets ratio of 33.5% as of September 2025. Working capital of ₩40.46 Billion (current assets of ₩83.17 Billion minus current liabilities of ₩42.70 Billion) is measured against net assets of ₩120.95 Billion. A higher ratio indicates strong short-term liquidity financed by the equity base.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Working Capital to Net Assets Ratio of HLB Pharmaceutical Co. Ltd (2014–2024)
Working capital to net assets ratio of HLB Pharmaceutical Co. Ltd from 2014 to 2024. This chart shows how HLB Pharmaceutical Co. Ltd's Working Capital to Net Assets ratio has evolved across 11 annual periods from 2014 to 2024. As of September 2025, the ratio stands at 33.5%, reflecting working capital of ₩40.46 Billion against net assets of ₩120.95 Billion KRW. Explore 047920 long-term investments to assets to see how much of total assets are deployed in long-term investments.
HLB Pharmaceutical Co. Ltd Working Capital to Net Assets Ratio by Year (2014–2024)
HLB Pharmaceutical Co. Ltd working capital to net assets ratio by year from 2014 to 2024. The table below presents the year-by-year Working Capital to Net Assets ratio for HLB Pharmaceutical Co. Ltd from 2014 to 2024, covering 11 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. For the complete balance sheet picture, see 047920 current and non-current assets.
| Year | WC/NA Ratio | Working Capital (KRW) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2024 | 21.3% | ₩24.75 Billion | ₩116.40 Billion | ₩63.38 Billion | ₩38.63 Billion | ▼ -4.5 pp |
| 2023 | 25.7% | ₩22.68 Billion | ₩88.15 Billion | ₩71.57 Billion | ₩48.90 Billion | ▲ +17.5 pp |
| 2022 | 8.2% | ₩7.09 Billion | ₩85.93 Billion | ₩59.95 Billion | ₩52.86 Billion | ▲ +0.6 pp |
| 2021 | 7.6% | ₩5.96 Billion | ₩78.38 Billion | ₩51.47 Billion | ₩45.51 Billion | ▼ -66.3 pp |
| 2020 | 73.9% | ₩33.00 Billion | ₩44.62 Billion | ₩94.98 Billion | ₩61.98 Billion | ▲ +39.8 pp |
| 2019 | 34.1% | ₩5.93 Billion | ₩17.36 Billion | ₩29.02 Billion | ₩23.09 Billion | ▲ +4.4 pp |
| 2018 | 29.7% | ₩5.05 Billion | ₩17.00 Billion | ₩21.28 Billion | ₩16.22 Billion | ▼ -3.2 pp |
| 2017 | 32.9% | ₩5.53 Billion | ₩16.80 Billion | ₩23.27 Billion | ₩17.74 Billion | ▼ -59.7 pp |
| 2016 | 92.6% | ₩17.50 Billion | ₩18.90 Billion | ₩24.36 Billion | ₩6.86 Billion | ▲ +26.1 pp |
| 2015 | 66.5% | ₩8.10 Billion | ₩12.18 Billion | ₩15.05 Billion | ₩6.96 Billion | ▲ +32.0 pp |
| 2014 | 34.4% | ₩1.66 Billion | ₩4.81 Billion | ₩13.36 Billion | ₩11.70 Billion | — |